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Summary 
Human African trypanosomiasis (HAT) is caused by Trypanosoma brucei 
gambiense and T. b. rhodesiense and caused devastating epidemics during the 20th 
century. Due to effective control programs implemented in the last two decades, the 
number of reported cases has fallen to a historically low level. Although fewer than 
977 cases were reported in 2018 in endemic countries, HAT is still a public health 
problem in endemic regions until it is completely eliminated. In addition, almost 150 
confirmed HAT cases were reported in non-endemic countries in the last three 
decades. The majority of non-endemic HAT cases were reported in Europe, United 
States and South Africa, due to historical alliances, economic links or geographic 
proximity to disease endemic countries. Furthermore, with the implementation of the 
“Belt and Road” project, sporadic imported HAT cases have been reported in China  
as a warning sign of tropical diseases prevention. In this paper, we explore and 
interpret the data on HAT incidence and find no positive correlation between the 
number of HAT cases from endemic and non-endemic countries.This data will 
provide useful information for better understanding the imported cases of HAT 
globally in the post-elimination phase. 
 
Key words: Human African trypanosomiasis; Trypanosoma brucei gambiense; T. b. 
rhodesiense; sub-Saharan Africa; non- endemic disease countries 
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Introduction     
Human African trypanosomiasis (HAT), also known as sleeping sickness, is a 
neglected tropical disease, which is found in 36 African endemic countries (Simarro et 
al., 2010). It is caused by subspecies of the parasitic protozoan Trypanosoma brucei 
and transmitted by tsetse flies. Two subspecies are able to infect humans: T. b. 
gambiense causes a chronic form of HAT in West and Central Africa, while T. b. 
rhodesiense is the pathogenic agent for the acute form of the disease in Eastern Africa 
(Barrett et al., 2003; Stich et al., 2002). In the last decade of the 20th century, the 
number of reported cases of HAT reached alarming levels with up to 50,000 new 
cases reported each year (Hide, 1999). Therefore, surveillance and control activities 
against HAT were reinforced at the beginning of the 21st century. These effective 
measures enabled a steady decrease in HAT cases (Franco et al., 2014a; WHO, 2013a). 
As a consequence, HAT was included in the WHO NTD roadmap of diseases targeted 
for elimination by 2020. The WHO definition of elimination for HAT is that the 
incidence is less than 1 new case per 10000 population in at least 90% of foci and 
with fewer than 2000 cases reported globally. According to this definition, the criteria 
for elimination was achieved in 2017. 
It is well-known that the prevalence of the pathogen, T. brucei is restricted to 
sub-Saharan Africa, due to the distribution limitations of its transmission vector, the 
tsetse flies of the genus Glossina (Migchelsen et al., 2011). However, human 
population movements, including travelling, business connections and migration may 
put people with little awareness of HAT in danger. This is evidenced by reports of 
HAT-positivity in some travelers, military personnel and immigrants. During the 
period 2000 to 2010, more than 100 cases of HAT were reported in 19 non-disease 
endemic countries (Simarro et al., 2012). According to the UN World Tourism 
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Organization, the number of international tourist arrivals increased from 25 million in 
1950 to 1035 million in 2012 (Norman et al., 2015). The strongest growth in 
international tourist arrivals was recorded in Asia, followed by the Pacific Region, 
Africa and the Americas. According to the Chinese government, the number of 
Chinese people living overseas has reached 60 million. Furthermore, approximately 
122 million Chinese people traveled overseas in 2016. Additionally, a large number 
(up to 52.67 million) non-Chinese travelers crossed China’s borders in 2014. 
Sino-overseas cooperation, triggered by the “Belt and Road Initiative”, has promoted 
the international movement of a huge population of both Chinese and non-Sino 
peoples and this will greatly increase the importation risk of tropical diseases that 
were not endemic in China. 
In this article, we critically analyze the incidence of human African 
trypanosomiasis (HAT) in endemic countries and non-endemic countries during the 
period between 1990 and 2018.  
 
Search strategy and selection criteria 
We searched PubMed for the terms “Trypanosoma brucei”, “Trypanosoma 
brucei gambiense”, “Trypanosoma brucei rhodesiense”, “Human African 
trypanosomiasis” to identify papers published between Jan 1, 1990 and Dec 31, 2018 
on Human African trypanosomiasis cases in non-endemic countries. Additionally, we 
reviewed relevant articles cited in those references and included them as primary 
sources when appropriate.  
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Incidence of human African trypanosomiasis in endemic countries 
from 1990-2018 
Human African trypanosomiasis was first described around the 14th century, but 
it can probably be considered as endemic in African regions since the appearance of 
humans. In the 20
th
 century, because of the socio-economic impact caused by HAT, 
effective measures were taken to control the disease. This resulted in it reaching a 
very low, generalized, transmission by the mid-1960s with a minimum of 4,435 cases 
declared in Africa in 1964 (WHO, 2013b). However, post-1960s, disease control 
interventions were constrained due to conflicts, insecurity and other social instability 
factors which largely resulted from the inevitable (and justifiable) emergence of 
independent African states from their former European colonizers. Unintentionally, 
this led to a resurgence of the disease in the 1980s and 1990s (Franco et al., 2014a,b). 
As a consequence, the number of sleeping sickness cases reached alarming levels such 
that by 1998 the newly reported cases were up to 37991 and the total number of 
existing cases of HAT was estimated at 300,000 cases (WHO, 1998). At that time, the 
status of HAT triggered attention from the health authorities in endemic countries 
alongside bilateral and multilateral agencies (Franco et al., 2014a, b). The World 
Health Organization (WHO) also responded to this situation by coordinating 
international partners working in HAT control, raising awareness and political will, 
and bringing new resources from the public and private sectors to support national 
control programs. Control programs were reinforced again and as a result, in the past 
20 years, important advances have been made in controlling this disease. A substantial, 
steady reduction in the number of cases has been observed, reaching the historical 
lowest figure in 2018 (Figure 1).  
Among the two species which cause human African trypanosomiasis, more than 
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90% of HAT cases were caused by T. b. gambiense (Figure 2A and 2B). It is worth 
noting that the cases in the Democratic Republic of the Congo (DRC) consistently 
accounted for the vast majority of gambiense-HAT cases. Especially in 1997 and 1998, 
increases in new cases of gambiense-HAT (25094 and 26318) in the DRC, led to a 
sharp increase in total number of gambiense-HAT cases. In addition, new cases of 
gambiense-HAT in Angola also sharply increased during this period due to civil war, 
as 6726, 8275 and 6610 new cases were reported in 1996, 1997 and 1998 respectively 
(Figure 2A, Table S1). However, the total number of reported cases of rhodesiense 
HAT has shown a gradual descending trend over nearly three decades. We found that 
almost all of new cases were reported in Uganda and United Republic of Tanzania, 
and the number of cases in both countries accounted for over 80% of all cases from 
1990 to 2007 (Figure 2B, Table S2). By 2008, the number of new reported cases 
dropped below 200 and less than 100 new cases were found in 2011. 
According to reports from WHO, less than 1500 new cases of HAT (including 
1420 new cases of T. b. gambiense (WHO, 2019a), representing about 98% of the 
total HAT cases, and 27 new cases of T. b. rhodesiense (WHO, 2019b), representing 
less than 2% of the total HAT cases) were recorded in 2017 (Table S1 and S2). As 
always, the majority of gambiense-HAT cases were distributed in the Democratic 
Republic of the Congo with up to 1110 cases (78% of the total gambiense-HAT) 
(Figure 3). Furthermore, 140 and 76 new cases of gambiense-HAT were reported in 
Guinea and the Central African Republic respectively. For the rest, less than 50 new 
cases of gambiense-HAT, were reported in Angola (18 cases), Cameroon (5 cases), 
Chad (28 cases), Congo (15 cases), Côte d'Ivoire (3 cases), Equatorial Guinea (4 
cases), Gabon (9 cases) and South Sudan (12 cases) respectively. To our knowledge, 
there are no reported gambiense-HAT cases in other West and Central Africa countries. 
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However, during 2017, there were only 27 reported new cases of rhodesiense-HAT in 
Eastern African endemic areas, these were distributed in Uganda (13 cases), Malawi 
(7 cases), United Republic of Tanzania (3 cases), Zambia (3 cases) and Zimbabwe (1 
case) respectively.  
Based on the latest reports from WHO (WHO, 2019a,b), the 
case numbers of HAT were down to their lowest-ever levels in 2018 and the total 
number of new cases was less than 1000, including 953 cases of T. b. gambiense, and 
24 new cases of T. b. rhodesiense. It was exciting that the number of reported 
gambiense-HAT cases from the Democratic Republic of the Congo was down to 660 
and the HAT cases from every other country numbered fewer than 100 (Figure 3B). 
Surprisingly, the case number in Angola increased from 18 (2017) to 79 (2018). For T. 
b. rhodesiense, new cases were only reported in Malawi (15 cases), Uganda (4 cases) 
and Zambia (5 cases) respectively in 2018. 
  
Cases of human African trypanosomiasis reported in non-disease 
endemic countries (DECs) 
The human African trypanosomiasis cases in non-endemic countries from 1990 
to 2010 have been collected in previous reports (Migchelsen et al., 2011; Simarro et 
al., 2012). Therefore, we will concentrate on cases in non-endemic countries reported 
between 2011 and 2018. A total of 15 cases of HAT were reported in 11 non-endemic 
countries (Figure 4; Table 1), including 9 cases of rhodesiense-HAT and 4 cases of 
gambiense-HAT and another 2 indeterminate cases (Table 1). Rhodesiense- HAT was 
mainly diagnosed in tourists after short visits to endemic countries, and the majority 
of them were in the first stage of disease. However, the majority of gambiense-HAT 
patients had been living in endemic countries for an extended period for various 
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reasons (eg. migrants or expatriates, etc). Therefore, by the time they were diagnosed, 
the disease had developed into the second stage. Due to historical or economic links 
with endemic countries and frequent travel to endemic countries, citizens from Europe 
have more chances of becoming infected with trypanosomes. More than half of the 
cases (8 cases, 53.3% of total) were diagnosed in European countries (including 
Belgium, 1 case; France, 1 case; Germany, 2 cases; Netherlands, 1 case; Spain, 1 case; 
and UK, 2 cases). In addition, another 2 cases were reported in North America 
(including one in Canada and one in USA) and South America (Argentina) 
respectively. The remaining 4 cases were identified in Asia. Interestingly, with the 
exception of 1 case from Israel, the other 3 HAT cases were all diagnosed in China, 
which is now starting to appear as a non-DEC with increasing numbers of imported 
HAT cases during the period of 2011 to 2018. 
Furthermore, the number of reported cases diagnosed in non-endemic countries 
between 2011 to 2018 were compared with previous records (Figure 5). It is reported 
that many more HAT cases were diagnosed in non-endemic countries from 2001 to 
2010 including 77 cases of rhodesiense-HAT and 31 cases of gambiense-HAT, as 
detailed in supplementary table 3. As shown in Figure 6, during this period of time, 
many imported HAT cases were diagnosed in South Africa (26 cases, accounting for 
24.1% of the total 108 cases). This is probably due to its proximity to endemic 
countries with famous protected areas and game reserves. In addition, due to historical 
or economic links with endemic countries, most of the HAT cases were diagnosed in 
North American and European countries, 21 and 53 cases, account for 19.4% and 
49.1%, respectively. Among them, the United States and United Kingdom contributed 
significant numbers of imported HAT cases (US, 18 cases; and the UK, 12 cases), 
followed by Netherlands (11), Italy (9), France (6) and Germany (5).  
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Only 21 cases of HAT (15 cases of rhodesiense-HAT and 6 cases of gambiense- 
HAT) were reported in non-endemic countries between 1990 to 2000 (Figure 5, Table 
S4). Among them, most cases were mainly diagnosed in the USA (6) and France (5), 
with the rest being diagnosed in the Netherlands (1), Germany (1), Italy (1), Mexico 
(1), New Zealand (1), South Africa (1), Switzerland (2) and the UK (2) (Figure 6). 
There was a resurgence of HAT in the 1990s, when the number of sleeping sickness 
cases reached the highest ever recorded in 1998. Why there is no positive correlation 
between number of HAT cases in non-endemic countries and endemic countries is 
puzzling? It may be that some HAT cases were not published in the literature or 
perhaps there have been some misdiagnosed cases in the past. However, from the 
beginning of this century, pharmacy services in non-endemic countries have had to 
request drugs from WHO to treat HAT cases and, at the same time, provide 
epidemiological, parasitological, biological, and clinical data. Therefore, this 
information has enabled WHO to maintain HAT surveillance system and a 
comprehensive database for non-endemic countries.  
 
The sources of imported HAT cases in non-endemic regions  
During the period from 1990 to 2018, more than 101 reported rhodesiense-HAT 
cases were exported from eastern and southern Africa (As shown in Table 2). It is 
supposed that the infection has been contracted in protected areas such as national 
parks (NP), wildlife reserves, and game reserves (Selby et al. 2013; Simarro et al., 
2012). The country exporting the majority of rhodesiense HAT cases is the United 
Republic of Tanzania, with up to 56.4% (57 cases). Other exporting countries are 
Malawi (15%, 15 cases), Zambia (9.9%, 10 cases), Zimbabwe (6%, 6 cases), Rwanda 
(5%, 5 cases), Kenya (3%, 3 cases) and Uganda (2%, 2 cases). However, the number 
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of rhodesiense HAT endemic cases in a country does not positively correlate with the 
number of cases exported. For example, from 1990 to 2000, there were no new cases 
reported in Rwanda, nevertheless it exported more than 5 cases to non-endemic areas 
from this country; while the maximum number of endemic cases was reported in the 
Uganda, but no cases were exported from this country. In addition, only 8 cases were 
reported in Zimbabwe from 2001 to 2010, but as many as 5 cases were exported 
during this period. Furthermore, the number of exported cases from Kenya is the same 
as the number of domestic cases from 2011 to 2018. Perhaps the factors underlying 
the export of cases are related more to the awareness of travelers and the messaging 
around risk in specific countries than biological factors such as the epidemiology of 
exposure. 
However, the majority of HAT cases were gambiense-HAT that were reported in 
western and central Africa, whereas there were only 40 cases of exported 
gambiense-HAT during 1990 to 2018 (Table 3). The countries of origin for exported 
gambiense-HAT are mainly the Gabon, Angola and DRC, each accounting for 25% 
(10 cases), 20% (8 cases) and 20% (8 cases), followed by Cameroon (10%, 4 cases), 
Equatorial Guinea, Nigeria, Central African Republic and Uganda (5%, 2 cases each), 
Sudan (2.5%, 1 case) and one uncertain case (2.5%) which may have originated 
from Nigeria or Gabon. To our surprise, as many as 7 and 3 cases were exported 
from Gabon and Cameroon respectively, despite numbers of indigenous cases being 
as low as 305 and 174 in these two countries from 2001 to 2010. In addition, 
although only 6 indigenous cases were reported in Nigeria, 1 case of exported HAT 
has been reported between 2011 and 2018. These seems to be a general lack of 
association between incidence and exported infections across many endemic 
countries. 
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HAT carriers may not be the main infective source for non-endemic 
countries  
In an analysis of the dynamic change trend of HAT cases diagnosed in 
non-endemic countries and endemic countries, we found that there is no positive 
correlation (P = 0.62) between the two groups (Figure 7). It is possible that the 
number of people traveling to eastern Africa, endemic areas of the rhodesiense-HAT, 
is higher than that in other regions. This suggestion is supported by the most recent 
tourism data (2018) that shows higher numbers of incoming tourists in East African 
DEC countries (e.g. Malawi, 870k; Zambia, 1072k; Tanzania, 1506k) compared with 
West African DEC countries (e.g. DRC, 351k (2016 data); Congo 158k) (UNWTO, 
2020). However, more than 70% of the cases reported from non-endemic countries 
were infected during trips to east African countries, in particular to popular tourist 
countries, such as Tanzania, Malawi or Zambia. By comparison, the overall 
proportion of rhodesiense-HAT cases reported from endemic countries accounts for 
only 10 percent of the total number of cases. 
Interestingly, inspection of the data presented in Figure 7 shows that peaks of 
reported non-DEC infections occur a few years after the corresponding peaks in DECs 
(see for example the endemic disease peak in 1997-1998 with the peak of reported 
cases in non DECs 2001-2002, four years later). This suggests that there might be a 
time delay between the local disease status in endemic countries and the recording of 
reported cases in non-DECs. Analysis of correlation between the number of cases in 
DECs with those reported from non-DECs shows a highly significant correlation (P = 
0.0011) when the comparative data sets are offset by 4 years (ie DEC data from 1990 
to 2014 compared year by year with non-DEC data from 1994 to 2018). Significant 
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correlations are additionally found when comparisons are offset by 3 to 7 years. Such 
a delay between the endemic peak could be attributed to the relatively long incubation 
period in T. b. gambiense infections, a delay in diagnosis or reporting of cases in the 
recipient non-DEC or a generic delay in reporting back to WHO. Comparable 
significant correlations were found when this analysis was carried out separately on T. 
b. gambiense data (e.g. P = 0.0009; 4 year offset data) but no correlation at all was 
seen when analyzing T. b rhodesiense non-DEC case data (e.g. P = 0.83; 4 year offset 
data). This broad analytical approach has many flaws but suggests that more detailed 
case information and better stratification of the data might tell us more about the role 
of HAT carriers or the reporting processes in non-DEC cases. 
In addition to human reservoirs, many livestock and wildlife species can act as 
animal reservoirs, from which T. b. gambiense and T. b. rhodesiense maybe spill over 
to humans (Büscher et al., 2017; Cecchi et al., 2014, 2015; Cordon-Obras et al., 2015; 
Jamonneau et al., 2004; Kageruka, 1989; Mehlitz, 1997; Molyneux, 1973; Njiokou et 
al., 2006; N’Djetchi et al., 2017; Simarro et al., 2010; Yesufu, 1971). It has been 
demonstrated that human-derived T. b. gambiense strains that were cyclically 
transmitted by tsetse flies between animals for more than a year remained 
transmissible to humans (Van Hoof, 1947). Compared to latent infections in humans, 
our current knowledge of T. b. gambiense and T. b. rhodesiense infections in animals 
is very limited and fragmented. Therefore, it is not known whether cryptic reservoirs 
in animals will compromise the sustainable elimination of human Africa 
trypanosomiasis.  
 
The risk of mechanical transmission of Trypanosoma spp. 
It is known that tsetse flies play the most important role, as cyclical vectors, in 
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the transmission of African human and livestock trypanosomes (Trypanosoma 
congolense, T. vivax, and T. brucei) (Desquesnes and Dia, 2003a,b; Hoare, 1972). 
However, previous research has demonstrated that many species of Trypanosoma can 
be mechanically transmitted by haematophagous insects or sucking flies (Desquesnes 
and Dia, 2003a,b). Importantly, T. brucei rhodesiense was reported to be mechanically 
transmitted by Musca sorbens, which could potentially pose a threat to human 
populations and livestock in non-endemic areas (Büscher et al., 2018; Simarro et al., 
2010). 
 
China as a new destination for imported cases 
Until recently, there have been no reported cases of trypanosomiasis in China. As 
China further develops international connections through economic development and 
tourism in African countries, the risk of the emergence of non-endemic cases in China 
will increase. Such a development may require a greater awareness, in the Chinese 
health systems, of the possible emergence of cases. Strikingly, there have been three 
cases of imported human African trypanosomasis in recent years, including 2 cases of 
T. b. gambiense, discovered in Chinese workers and presumably infected in Gabon, 
Western Africa; whereas another case of T. b. rhodesiense was found in a Chinese 
tourist visiting game parks in Tanzania, Eastern Africa (Zhou et al., 2018). According 
to the Chinese government, approximately 60 million Chinese people are now living 
overseas and in 2016, more than 122 million Chinese people travelled overseas 
(IOMMA, 2017). Additionally, the number of visitors entering China numbered up to 
52.67 million in 2014 (CNTA, 2016). Therefore, economic globalization and 
population migration will increase the importation risk of tropical diseases that were 
not previously endemic in China and, of course, other countries too. This situation 
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may be mitigated as African countries are now moving into the elimination phase of 
sleeping sickness but the situation needs to be monitored in the possible event of any 
post-elimination resurgence of disease. 
 
Conclusions  
Sleeping sickness, also known as human African trypanosomiasis (HAT), is a 
neglected disease that impacts 70 million people living in 1.55 million km
2
 in 
sub-Saharan Africa (Aksoy et al., 2017). The successful control activities carried out 
over the last less 20 years have substantially reduced the burden of disease. According 
to the latest report from WHO (WHO, 2019a,b), new cases of HAT were less than 
1000 in 2018 (98% of total HAT is T. b. gambiense, while T. b. rhodesiense is less 
than 2%). However, in some rural areas where trypanosomiasis is prevalent, the 
overall performance of peripheral health systems is often weak and characterized by 
unskilled staff, low attendance and low coverage. 
Furthermore, political instability and insecurity are inescapable challenges in an 
elimination programme. Gambiense-HAT does not spread easily and humans are the 
only significant reservoir. The successful elimination of gambiense-HAT requires a 
turmoil-free socio-political context. However, the elimination of rhodesiense-HAT 
poses challenges because of the vast animal reservoirs. 
Therefore, the strengthening of health systems to implement the activities 
included in the elimination strategies is essential. Past and current experiences show 
that HAT elimination is difficult and will require more effort, time, and money than 
initially anticipated. History teaches us that falling case numbers can result in a 
decline in donor and control agency interest, opening the door to swift and severe 
recrudescence (Büscher et al., 2017). Advocacy is needed to sensitize donors on the 
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importance of switching from a control to an elimination mindset. 
It is known that the majority of HAT cases reported by endemic countries 
correspond to the gambiense form (98%), the opposite is true for imported cases in 
non-endemic countries, where 72% of cases are caused by T. b. rhodesiense and 28% 
by T. b. gambiense. However, the proportion of gambiense- to rhodesiense-HAT cases 
diagnosed in non-endemic countries is lower than one would probably expect. 
Moreover, it is difficult to establish the number of migrants and refugees traveling to 
non-endemic countries from HAT transmission areas, and even more difficult to 
ascertain how many of them are affected by HAT. Therefore, it is a potential threat to 
non-endemic countries because global mobility means that Trypanosoma brucei can 
be spread in many ways.   
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Table 1. Cases of human African trypanosomiasis (HAT) recorded in non-endemic countries from 2011 to 2018. 
Cases
Refs
 Time Place of diagnosis Place of infection Sex/age Activity Stage Chancre Species 
1
(Wijsman et al., 2018)
 2018* NA Netherlands Tanzania and Kenya W56 Traveller 1 Yes T. b. (unknown) 
2
(Wang et al., 2018)
 2017 August China Libreville，Gabon M60 worker 2 NA T. b. gambiense 
3
(Liu et al., 2018)
 2017 August China 
Masai Mara area in Kenya and the 
Serengeti area in Tanzania 
W41 Traveller 1 Yes T. b. rhodesiense 
4
(Streit and Matsumoto, 2016)
 2016* December USA Botswana and Zimbabwe W60 Traveller 1 NA T. b. rhodesiense 
5
(Luintel et al., 2017)
 2016 August UK Delta State, Nigeria W58 NA 2 NA T. b. gambiense 
6
(De Kyvon et al., 2016)
 2016* May France Democratic Republic of the Congo M14month Delivery 2 NA T. b. gambiense 
7
(Gomez-Junyent et al., 2017)
 2015 August Spain Tanzania W49 Traveller 1 Yes T. b. rhodesiense 
8
(Hu et al., 2016)
 2014 September China Gabon M45 Sailor 2 Yes T. b. gambiense 
9
(Pale et al., 2013)
 2013* August Argentina Zambia M65 Traveller NA NA T. b. rhodesiense 
10
(Pasternak et al., 2013)
 2013* January Canadian Zimbabwe M Traveller 1 NA T. b. rhodesiense 
11
(Clerinx et al., 2012)
 2012 February Belgium 
Masai Mara National Reserve in 
Kenya 
M Traveller 
NA 
Yes T. b. rhodesiense 
12
(Wolf et al., 2012)
 2012 January Germany Masai Mara area in Kenya M62 Traveller 1 NA T. b. rhodesiense 
13
(Meltzer et al., 2012)
 2012* NA Israeli Tanzania W31 Traveller 1 NA T. b. rhodesiense 
14
(Richter et al., 2012)
 2012* March Germany Zambia M58 Traveller NA NA T. b. (unknown) 
15
(Cottle et al., 2012)
 2012* February UK Zambia W49 Traveller 1 NA T. b. rhodesiense 
*: Time refers to the published date when the diagnostic date is unavailable. 
NA: Information is unavailable on the case report 
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Table 2. Summary of rhodesiense-HAT cases in eastern African countries but reported in endemic countries or non-endemic countries. 
 
1990-2000  2001-2010  2011-2018 
Total in non-DECs 
DECs Non-DECs  DECs Non-DECs  DECs Non-DECs 
Kenya 164 1  23 0  2 2 3 
Malawi 736 1  465 14  180 0 15 
Rwanda 0 5  0 0  0 0 5 
Tanzania 3424 6  1294 49  16 2 57 
Tanzania or kenya •• ••  •• ••  •• 1 1 
Tanzania, Kenya or Rwanda •• 1  •• ••  •• •• 1 
Uganda 5458 0  2660 2  319 0 2 
Zambia 41 1  81 7  42 2 10 
Zimbabwe 10 0  8 5  22 1 6 
Zimbabwe or Botswana •• ••  •• ••  •• 1 1 
Total in non-DECs •• 15  •• 77  •• 9 101 
DECs=Disease endemic countries; Non-DECs= Non-disease endemic countries. 
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Table 3. Summary of gambiense-HAT cases in west and central African countries but reported in endemic countries or non-endemic 
countries. 
 
1990-2000  2001-2010  2011-2018 
Total in non-DECs 
DECs Non-DECs  DECs Non-DECs  DECs Non-DECs 
Angola 43017 1  18048 7  402 0 8 
Cameroon 360 1  174 3  52 0 4 
Central African Republic 6320 0  6990 2  1090 0 2 
DRC 176073 1  99451 6  25635 1 8 
Eq. Guinea 515 0  165 2  13 0 2 
Gabon 451 1  305 7  81 2 10 
Nigeria 65 1  107 0  6 1 2 
Nigeria or Gabon •• 1  •• ••  •• •• 1 
Sudan 6073 0  14149 1  843 0 1 
Uganda 14790 0  2928 2  90 0 2 
Total in non-DECs •• 6  •• 30  •• 4 40 
DECs=Disease endemic countries; Non-DECs= Non-disease endemic countries. 
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Figure legends. 
 
Fig. 1. Total number of reported cases of HAT in endemic countries from 1990 - 2018. 
Note: Data taken from the World Health Organization. 
 
Fig. 2. (A) Number of reported cases of gambiense-HAT per year from 1990 -2018 in 
endemic countries with a breakdown for each country. (B) Number of reported cases 
of rhodesiense-HAT per year from 1990 -2018 in endemic countries with a breakdown 
for each country. Data taken from the World Health Organization (WHO). 
 
https://doi.org/10.1017/S0031182020000645
Downloaded from https://www.cambridge.org/core. University of Salford, on 11 May 2020 at 09:22:59, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms.
  
 
Fig. 3. Distribution of human African trypanosomiasis in endemic countries, 2017 and 
2018. Data taken from the World Health Organization (WHO). 
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Fig. 4. HAT cases that were diagnosed and confirmed in non-endemic countries from 
2011–2018. (A) (B) Dots represent the place of diagnosis; (C) Triangles indicate the 
probable place of infection. Numbers refer to the designations in Table 1. 
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Fig. 5. Number of HAT cases diagnosed in non-endemic countries in different 
periods. 
 
Fig. 6. HAT cases reported in non-endemic countries in different time periods. 
 
Fig. 7. The dynamic trend changes in HAT cases diagnosed in non-DECs and DECs. 
Bar graphs indicate the annual figures. The line graphs indicate the distribution 
of 3 year averages. 
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